WW Reports Q4 2025 Earnings: Revenue Declines but Clinical Subscribers Grow
WW (NASDAQ: WW) reported total revenue of $163 million for the fourth quarter, a 12% year-over-year decline. The drop was driven by an 17% decrease in behavioral revenue despite clinical revenue growing 32%. Adjusted EBITDA reached $18 million with a margin of 11.1%, and cash reserves stood at $160 million.
Tickers: $WW
Topics: adjusted_ebitda debt_reduction revenue subscriber_growth